Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Goodwill & Intangibles (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Goodwill & Intangibles for 3 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 35.99% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 35.99% decrease, with the full-year FY2024 number at $2.2 million, down 2.61% from a year prior.
  • Goodwill & Intangibles was $1.4 million for Q3 2025 at bioAffinity Technologies, down from $2.2 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $3.6 million in Q1 2024 to a low of $1.4 million in Q2 2024.
  • A 3-year average of $2.1 million and a median of $2.2 million in 2024 define the central range for Goodwill & Intangibles.
  • Biggest YoY gain for Goodwill & Intangibles was 53.11% in 2025; the steepest drop was 61.29% in 2025.
  • bioAffinity Technologies' Goodwill & Intangibles stood at $2.2 million in 2023, then dropped by 2.61% to $2.2 million in 2024, then plummeted by 35.56% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Goodwill & Intangibles are $1.4 million (Q3 2025), $2.2 million (Q2 2025), and $1.4 million (Q1 2025).